A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.
about
Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies.Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients.
P2860
A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@en
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@nl
type
label
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@en
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@nl
prefLabel
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@en
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@nl
P2093
P2860
P921
P1476
A Phase II Trial of Cetuximab, ...... tic Pancreatic Adenocarcinoma.
@en
P2093
Bilal Piperdi
Christine Mikule
Giles F Whalen
Jennifer F Tseng
Shakeeb Yunus
Sidney P Kadish
Steven R Grossman
Thomas J Fitzgerald
Venu Bathini
Volkan Cetin
P2860
P433
P577
2013-07-01T00:00:00Z